skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Long-term exposure to outdoor air pollution linked to increased risk of dementia

Long-term exposure to outdoor air pollution linked to increased risk of dementia

8 September 2025

An analysis of studies incorporating data from almost 30 million people has highlighted the role that air pollution – including that coming from car exhaust emissions – plays in increased risk of dementia. Dementias such as Alzheimer's disease are estimated to affect more than 57.4 million people worldwide, a number that...


Read more at: Brain cancer cells can be ‘reprogrammed’ to stop them from spreading

Brain cancer cells can be ‘reprogrammed’ to stop them from spreading

8 September 2025

Scientists have found a way to stop brain cancer cells spreading by essentially ‘freezing’ a key molecule in the brain. The finding could pave the way for a new type of treatment for glioblastoma, the most aggressive form of brain cancer, although extensive testing will be required before it can be trialled in patients...


Read more at: Why common blood pressure readings may be misleading – and how to fix them

Why common blood pressure readings may be misleading – and how to fix them

27 August 2025

Researchers have found why common cuff-based blood pressure readings are inaccurate and how they might be improved, which could improve health outcomes for patients. High blood pressure, or hypertension, is the top risk factor for premature death, associated with heart disease, strokes and heart attacks. However...


Read more at: Cambridge researchers play key role in evidence leading to approval of new treatment for hereditary blindness

Cambridge researchers play key role in evidence leading to approval of new treatment for hereditary blindness

27 August 2025

The National Institute for Health and Care Excellence (NICE) has today announced the approval of a new treatment for a form of hereditary blindness for use on the NHS in England. Cambridge researchers played a pivotal role in providing the evidence that led to this important development. Leber hereditary optic neuropathy (...


Read more at: Artificial heart valve found to be safe following long-term test in animals

Artificial heart valve found to be safe following long-term test in animals

27 August 2025

An artificial heart valve made from a new type of plastic could be a step closer to use in humans, following a successful long-term safety test in animals. A research team, led by the Universities of Bristol and Cambridge, demonstrated that the polymer material used to make the artificial heart valve is safe following a...


Read more at: Gone but not forgotten: brain’s map of the body remains unchanged after amputation

Gone but not forgotten: brain’s map of the body remains unchanged after amputation

27 August 2025

The brain holds a ‘map’ of the body that remains unchanged even after a limb has been amputated, contrary to the prevailing view that it rearranges itself to compensate for the loss, according to new research from scientists in the UK and US. The findings, published today in Nature Neuroscience, have implications for the...


Read more at: British Academy elects 12 Cambridge researchers to Fellowship in 2025

British Academy elects 12 Cambridge researchers to Fellowship in 2025

30 July 2025

Twelve academics from the University of Cambridge have been made Fellows of the prestigious British Academy for the humanities and social science They are among 92 distinguished scholars to be elected to the fellowship in recognition of their work in fields ranging from medieval history to international relations. It...


Read more at: Cambridge and AstraZeneca: a decade of partnership and impact

Cambridge and AstraZeneca: a decade of partnership and impact

30 July 2025

The University of Cambridge and AstraZeneca have a long history of scientific collaboration. In 2013, AstraZeneca’s decision to move its global headquarters and new strategic R&D centre to Cambridge started a new chapter of partnership. AstraZeneca chose Cambridge – the largest life science cluster in Europe – for its...


Read more at: Cambridge part of new Global Talent Fund plan to attract world’s best R&D to UK

Cambridge part of new Global Talent Fund plan to attract world’s best R&D to UK

30 July 2025

Cambridge University has been selected as a partner in a key Government initiative to attract more of the world’s best research talent to the UK. Because of its track record in recruiting and supporting top international researchers, the University will get a share of the new £54 million Global Talent Fund , along with 12...


Read more at: Mice are vital in the search for effective new dementia treatments

Mice are vital in the search for effective new dementia treatments

30 July 2025

Cambridge researchers are leading drug discovery to develop safer, more effective treatments for the millions of people affected by Alzheimer’s and other neurodegenerative diseases. According to Alzheimer’s Research UK, if nothing changes one in two of us will be affected by dementia in our lifetime, either by caring for...